Literature DB >> 21544694

Candida and invasive candidiasis: back to basics.

C S-Y Lim1, R Rosli, H F Seow, P P Chong.   

Abstract

The ubiquitous Candida spp. is an opportunistic fungal pathogen which, despite treatment with antifungal drugs, can cause fatal bloodstream infections (BSIs) in immunocompromised and immunodeficient persons. Thus far, several major C. albicans virulence factors have been relatively well studied, including morphology switching and secreted degradative enzymes. However, the exact mechanism of Candida pathogenesis and the host response to invasion are still not well elucidated. The relatively recent discovery of the quorum-sensing molecule farnesol and the existence of quorum sensing as a basic regulatory phenomenon of the C. albicans population behavior has revolutionized Candida research. Through population density regulation, the quorum-sensing mechanism also controls the cellular morphology of a C. albicans population in response to environmental factors, thereby, effectively placing morphology switching downstream of quorum sensing. Thus, the quorum-sensing phenomenon has been hailed as the 'missing piece' of the pathogenicity puzzle. Here, we review what is known about Candida spp. as the etiological agents of invasive candidiasis and address our current understanding of the quorum-sensing phenomenon in relation to virulence in the host.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21544694     DOI: 10.1007/s10096-011-1273-3

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  105 in total

Review 1.  The distinct morphogenic states of Candida albicans.

Authors:  Peter Sudbery; Neil Gow; Judith Berman
Journal:  Trends Microbiol       Date:  2004-07       Impact factor: 17.079

2.  Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.

Authors:  M A Pfaller; D J Diekema; M G Rinaldi; R Barnes; B Hu; A V Veselov; N Tiraboschi; E Nagy; D L Gibbs
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

3.  Stimulation of macrophage inflammatory protein-1alpha, macrophage inflammatory protein-1beta, and RANTES by Candida albicans and Cryptococcus neoformans in peripheral blood mononuclear cells from persons with and without human immunodeficiency virus infection.

Authors:  C Huang; S M Levitz
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

Review 4.  [Invasive fungal infections in patients after liver transplantation].

Authors:  L Fischer; M Sterneck
Journal:  Mycoses       Date:  2005       Impact factor: 4.377

5.  Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis.

Authors:  Dhammika H M L P Navarathna; Jacob M Hornby; Natasha Hoerrmann; Anne M Parkhurst; Gerald E Duhamel; Kenneth W Nickerson
Journal:  J Antimicrob Chemother       Date:  2005-10-20       Impact factor: 5.790

6.  Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1.

Authors:  J F Staab; S D Bradway; P L Fidel; P Sundstrom
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

Review 7.  Distinct protective host defenses against oral and vaginal candidiasis.

Authors:  Paul L Fidel
Journal:  Med Mycol       Date:  2002-08       Impact factor: 4.076

8.  Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection.

Authors:  Stephen P Saville; Anna L Lazzell; Carlos Monteagudo; Jose L Lopez-Ribot
Journal:  Eukaryot Cell       Date:  2003-10

9.  Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program.

Authors:  Rana A Hajjeh; Andre N Sofair; Lee H Harrison; G Marshall Lyon; Beth A Arthington-Skaggs; Sara A Mirza; Maureen Phelan; Juliette Morgan; Wendy Lee-Yang; Meral A Ciblak; Lynette E Benjamin; Laurie Thomson Sanza; Sharon Huie; Siew Fah Yeo; Mary E Brandt; David W Warnock
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

10.  Hgc1, a novel hypha-specific G1 cyclin-related protein regulates Candida albicans hyphal morphogenesis.

Authors:  Xinde Zheng; Yanming Wang; Yue Wang
Journal:  EMBO J       Date:  2004-04-08       Impact factor: 11.598

View more
  29 in total

1.  Artemisinins, new miconazole potentiators resulting in increased activity against Candida albicans biofilms.

Authors:  Kaat De Cremer; Ellen Lanckacker; Tanne L Cools; Marijke Bax; Katrijn De Brucker; Paul Cos; Bruno P A Cammue; Karin Thevissen
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

Review 2.  Dual targeting strategies with bispecific antibodies.

Authors:  Roland E Kontermann
Journal:  MAbs       Date:  2012-03-01       Impact factor: 5.857

3.  Inactivation of the antifungal and immunomodulatory properties of human cathelicidin LL-37 by aspartic proteases produced by the pathogenic yeast Candida albicans.

Authors:  Maria Rapala-Kozik; Oliwia Bochenska; Marcin Zawrotniak; Natalia Wolak; Grzegorz Trebacz; Mariusz Gogol; Dominika Ostrowska; Wataru Aoki; Mitsuyoshi Ueda; Andrzej Kozik
Journal:  Infect Immun       Date:  2015-04-06       Impact factor: 3.441

Review 4.  Histone deacetylase-mediated morphological transition in Candida albicans.

Authors:  Jueun Kim; Ji-Eun Lee; Jung-Shin Lee
Journal:  J Microbiol       Date:  2015-12-02       Impact factor: 3.422

5.  A five-year retrospective descriptive study on the clinical characteristics and outcomes of candidaemia at a tertiary hospital in South Africa.

Authors:  Maleeha Hussain; Andrew Whitelaw; Arifa Parker
Journal:  IJID Reg       Date:  2022-03-03

6.  Hemolytic factor production by clinical isolates of Candida species.

Authors:  Daniel Favero; Luciana Furlaneto-Maia; Emanuele J G França; Helena Peggau Góes; Marcia Cristina Furlaneto
Journal:  Curr Microbiol       Date:  2013-09-19       Impact factor: 2.188

Review 7.  Candida glabrata: a review of its features and resistance.

Authors:  C F Rodrigues; S Silva; M Henriques
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-11-19       Impact factor: 3.267

Review 8.  The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives.

Authors:  Christophe d'Enfert; Ann-Kristin Kaune; Leovigildo-Rey Alaban; Sayoni Chakraborty; Nathaniel Cole; Margot Delavy; Daria Kosmala; Benoît Marsaux; Ricardo Fróis-Martins; Moran Morelli; Diletta Rosati; Marisa Valentine; Zixuan Xie; Yoan Emritloll; Peter A Warn; Frédéric Bequet; Marie-Elisabeth Bougnoux; Stephanie Bornes; Mark S Gresnigt; Bernhard Hube; Ilse D Jacobsen; Mélanie Legrand; Salomé Leibundgut-Landmann; Chaysavanh Manichanh; Carol A Munro; Mihai G Netea; Karla Queiroz; Karine Roget; Vincent Thomas; Claudia Thoral; Pieter Van den Abbeele; Alan W Walker; Alistair J P Brown
Journal:  FEMS Microbiol Rev       Date:  2021-05-05       Impact factor: 16.408

9.  Candida albicans isolates from the gut of critically ill patients respond to phosphate limitation by expressing filaments and a lethal phenotype.

Authors:  Kathleen Romanowski; Alexander Zaborin; Vesta Valuckaite; Ronda J Rolfes; Trissa Babrowski; Cindy Bethel; Andrea Olivas; Olga Zaborina; John C Alverdy
Journal:  PLoS One       Date:  2012-01-13       Impact factor: 3.240

10.  Treatment of invasive candidiasis in the elderly: a review.

Authors:  Aikaterini Flevari; Maria Theodorakopoulou; Aristea Velegraki; Apostolos Armaganidis; George Dimopoulos
Journal:  Clin Interv Aging       Date:  2013-09-09       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.